The research opens up new opportunities for treatment and diagnosis.
The researchers used a drug that inhibits NGFR and found that it helped to deter the cancer from spreading in mice.
“This drug needs a lot of testing,” Dr Lyden explained.
“Eventually, I think an NGFR inhibitor could be used in the clinical setting.
“We also would like to determine if we can use a simple blood test to see whether exosomes are carrying NGFR.
“This would help doctors to look at exosome NGFR over time during therapy to see how treatments should be adjusted.”